Concord Medical Services Holdings (CCM) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.008x

Based on the latest financial reports, Concord Medical Services Holdings (CCM) has a cash flow conversion efficiency ratio of 0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.03 Million) by net assets ($2.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Concord Medical Services Holdings for the company's overall valuation and market capitalisation.

Concord Medical Services Holdings - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Concord Medical Services Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Concord Medical Services Holdings Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Concord Medical Services Holdings ranked by their cash flow conversion efficiency. Explore Concord Medical Services Holdings cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Pertama Digital Berhad
KLSE:8532
-0.001x
Palamina Corp
V:PA
-1.095x
Copaur Minerals Inc
V:CPAU
-0.008x
Avrasya Petrol ve Turistik Tesisler Yatirimlar AS
IS:AVTUR
0.010x
Panda Financial Holding Corp Ltd
SHG:600599
0.403x
Nusa Palapa Gemilang PT Tbk
JK:NPGF
0.084x
J D Wetherspoon PLC
LSE:JDW
0.175x
TME PHARM.CONF.IPO EO 1-
F:0N6A
N/A

Annual Cash Flow Conversion Efficiency for Concord Medical Services Holdings (2007–2025)

The table below shows the annual cash flow conversion efficiency of Concord Medical Services Holdings from 2007 to 2025. View Concord Medical Services Holdings stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.85 Billion $-201.82 Million -0.109x +55.63%
2024-12-31 $1.62 Billion $-397.75 Million -0.246x -55.36%
2023-12-31 $1.75 Billion $-276.47 Million -0.158x -47.21%
2022-12-31 $2.02 Billion $-216.69 Million -0.108x +17.91%
2021-12-31 $2.74 Billion $-359.31 Million -0.131x -36.84%
2020-12-31 $2.40 Billion $-229.77 Million -0.096x +7.44%
2019-12-31 $1.89 Billion $-195.35 Million -0.103x -509.26%
2018-12-31 $2.27 Billion $-38.59 Million -0.017x -164.43%
2017-12-31 $1.01 Billion $26.73 Million 0.026x +141.55%
2016-12-31 $1.23 Billion $-78.08 Million -0.063x +48.11%
2015-12-31 $1.43 Billion $-175.14 Million -0.122x -144.84%
2014-12-31 $1.80 Billion $490.38 Million 0.272x +156.21%
2013-12-31 $2.44 Billion $259.03 Million 0.106x -4.05%
2012-12-31 $2.34 Billion $259.51 Million 0.111x +64.74%
2011-12-31 $2.04 Billion $137.10 Million 0.067x -18.92%
2010-12-31 $2.30 Billion $190.97 Million 0.083x +31.50%
2009-12-31 $2.15 Billion $135.88 Million 0.063x -23.79%
2008-12-31 $565.02 Million $46.77 Million 0.083x -35.52%
2007-12-31 $54.13 Million $6.95 Million 0.128x --

About Concord Medical Services Holdings

NYSE:CCM USA Medical Care Facilities
Market Cap
$10.45 Million
Market Cap Rank
#27051 Global
#5615 in USA
Share Price
$3.71
Change (1 day)
-0.80%
52-Week Range
$3.43 - $6.90
All Time High
$53.10
About

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other tre… Read more